Clinical Trial Update: A Dose Escalation With Expansion Study of EMB-01 in Participants With Advanced/Metastatic Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

A dose-escalation with expansion study of EMB-01 in advanced/metastatic solid tumors is underway across Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neoplasm Metastasis
• Neoplasms
• Non-small Cell Lung Cancer

Drugs mentioned

• EMB-01

Snippet

Sponsor: Shanghai EpimAb Biotherapeutics Co., Ltd. | Conditions: Neoplasms, Neoplasm Metastasis | Phase 1, Phase 2 | Status: UNKNOWN